Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocytemia

Thrombosis Research

Volumn 129, Issue 1, 2012, Pages 91-94

  Dillinger, Jean Guillaume ^a   Sollier, Claire Bal Dit ^a   Sideris, Georgios ^a   Ronez, Emily ^a   Henry, Patrick ^a   Drouet, Ludovic ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; LYSINE ACETYLSALICYLATE; THROMBOXANE A2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EVENING DOSAGE; FEMALE; HUMAN; MALE; MORNING DOSAGE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTHEMIA; THROMBOSIS; THROMBOSIS PREVENTION;

EID: 84655162752     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.09.017     Document Type: Letter

References (21)

1. A. Tefferi, J. Thiele, A. Orazi, H.M. Kvasnicka, T. Barbui, and C.A. Hanson Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel Blood 110 4 2007 1092 1097 (Pubitemid 47281402)
2. A.I. Schafer Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia Blood 107 11 2006 4214 4222 (Pubitemid 43801343)
3. A.I. Schafer Thrombocytosis N Engl J Med 350 12 2004 1211 1219 (Pubitemid 38339365)
4. R.B. Davis Acute thrombotic complications of myeloproliferative disorders in young adults Am J Clin Pathol 84 2 1985 180 185 (Pubitemid 15249744)
5. H.M. Rinder, J.E. Schuster, C.S. Rinder, C. Wang, H.J. Schweidler, and B.R. Smith Correlation of thrombosis with increased platelet turnover in thrombocytosis Blood 91 4 1998 1288 1294 (Pubitemid 28086882)
6. A. Tefferi Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management Am J Hematol 86 3 2011 292 301
7. A. Dragani, S. Pascale, A. Recchiuti, D. Mattoscio, S. Lattanzio, and G. Petrucci The contribution of cyclooxygenase-1 and - 2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy Blood 115 5 2010 1054 1061
8. P. Henry, A. Vermillet, B. Boval, C. Guyetand, T. Petroni, and J.G. Dillinger 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease Thromb Haemost 105 2 2011 336 344
9. J.B. Muhlestein Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients Thromb Haemost 103 1 2010 71 82
10. J.R. O'Brien Effect of salicylates on human platelets Lancet 1 7557 1968 1431
11. S.B. Mortensen, S.B. Larsen, E.L. Grove, S.D. Kristensen, and A.M. Hvas Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus Thromb Res 126 4 2010 e318 e322
12. E.L. Grove, A.M. Hvas, S.B. Mortensen, S.B. Larsen, and S.D. Kristensen Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease J Thromb Haemost 9 1 2011 185 191
13. G. Di Minno, M.J. Silver, and S. Murphy Monitoring the entry of new platelets into the circulation after ingestion of aspirin Blood 61 6 1983 1081 1085 (Pubitemid 13099894)
14. G. DiMinno, M.J. Silver, A.M. Cerbone, and S. Murphy Trial of repeated low-dose aspirin in diabetic angiopathy Blood 68 4 1986 886 891 (Pubitemid 17183848)
15. G. Montalescot, G. Sideris, C. Meuleman, C. Bal-dit-Sollier, N. Lellouche, and P.G. Steg A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial J Am Coll Cardiol 48 5 2006 931 938 (Pubitemid 44292463)
16. G.J. Hankey, and J.W. Eikelboom Aspirin resistance Lancet 367 9510 2006 606 617 (Pubitemid 43250663)
17. C. Perneby, N.H. Wallen, C. Rooney, D. Fitzgerald, and P. Hjemdahl Dose- and time-dependent antiplatelet effects of aspirin Thromb Haemost 95 4 2006 652 658
18. E.L. Grove, A.M. Hvas, H.L. Johnsen, S.S. Hedegaard, S.B. Pedersen, and J. Mortensen A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease Thromb Haemost 103 6 2010 1245 1253
19. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, and E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 6 2003 961 965 (Pubitemid 36315537)
20. M. Lordkipanidze, C. Pharand, E. Schampaert, J. Turgeon, D.A. Palisaitis, and J.G. Diodati A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease Eur Heart J 28 14 2007 1702 1708 (Pubitemid 47227104)
21. C. Patrono, and B. Rocca Drug insight: aspirin resistance-fact or fashion? Nat Clin Pract Cardiovasc Med 4 1 2007 42 50 (Pubitemid 44971071)